The Dermatology Devices Market Size was valued at USD 8.94 billion in 2023, and is expected to reach USD 21.06 billion by 2031, and grow at a CAGR of 11.92% over the forecast period 2024-2031.
Devices for dermatology are used to treat skin conditions. Dermatology deals with serious skin problems, arrangements, decisions, illnesses, or concerns connected to cosmetic issues. Lasers, RF equipment, microdermabrasion tools, and other ancillary items are examples of dermatology devices. These tools are put in hospitals and dermatological offices to help medical professionals and non-medical practitioners identify skin cancer and treat skin problems.
Get more information on Dermatology Devices Market - Request Sample Report
DRIVERS
Skin conditions are becoming more common
More cosmetic procedures being performed
Advancements in technology
More money being spent on healthcare
RESTRAINTS
Medical devices are subject to strict regulatory policies.
Uncertainty and problems with reimbursement
OPPORTUNITIES
Economies in transition
CHALLENGES
The Dermatology Devices Market is being threatened by low-cost manufacturers' aggressive pricing strategies and the availability of low-cost alternatives.
The development and expansion of the Dermatology Diagnostic Devices Market were interrupted by the coronavirus sickness. It led to numerous businesses closing down around the world for several months. This has considerably accelerated market growth and sparked a trend toward internet shopping. However, this element started to serve as a growth factor. Nevertheless, market opening and developments by industry participants will resume will further boost market expansion.
By Product type
The diagnostic and therapy segments of the dermatological device market are separated. During the projection period, the segment for treatment devices is anticipated to generate the largest revenue. This is explained by the increase in demand for dermatology tools that aid in disease management. Additionally, an increase in surgical operations using these dermatology devices would fuel market expansion over the next years. However, it is anticipated that diagnostic devices would account for sizable revenue shares in the dermatology devices market.
By Application type
The diagnosis of skin cancer, psoriasis, skin rejuvenation, and warts are the segments of the dermatological devices industry. Due to the rising incidence of skin cancer, which requires early diagnosis, the skin cancer diagnosis segment is expected to generate the most revenue during the projection period. The segment would also produce bigger revenue shares in the upcoming years thanks to expanding studies on skin cancer diagnosis for treating skin-related disorders.
By End user type
The hospitals, clinics, and other segments of the market for dermatology devices. Due to an increase in the number of outpatients who prefer clinics, it is predicted that the clinics category would generate the most income throughout the forecast period. In the coming years, the segment will also earn a sizeable market share because to the availability of experienced specialists for performing diagnostics and increasing investments made by specialty clinics to adopt cutting-edge product kinds.
By Product type
Diagnostic Devices
Imaging devices
Dermatoscopes
Microscopes
Treatment Devices
Electrosurgery Devices
Cryotherapy Devices
Laser Devices
By Application type
Skin Cancer Diagnosis
Psoriasis
Skin Rejuvenation
Warts
By End user type
Hospitals
Clinics
.png)
Need any customization research on Dermatology Devices Market - Enquiry Now
The dermatology device market is expected to be dominated by North America, with other regions following. Improvements in healthcare infrastructure, services provided to emerging nations, and an increase in public health awareness are just a few of the reasons why North America holds a higher market share. In North America as a whole, both developing and developed regions are expected to experience a rapid increase in demand for dermatology equipment in the future years.
REGIONAL COVERAGE
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Some of the major key players are as Ambicare Health, 3Derm Systems Inc., Cuter Inc., Alma Lasers Ltd., Candela Corporation, Galderma S.A., V. Genentech Inc., Cynosure Inc., Michelson Diagnostics Ltd., Lumenis Ltd., Valeant Pharmaceuticals and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 8.94 Billion |
| Market Size by 2031 | US$ 21.06 Billion |
| CAGR | CAGR of 11.92% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product type (Diagnostic Devices (Imaging devices, Dermato scopes, Microscopes), Treatment Devices (Electrosurgery Devices, Cryotherapy Devices, Laser Devices) • By Application type (Skin Cancer Diagnosis, Psoriasis, Skin Rejuvenation, Warts) • By End user type (Hospitals, Clinics) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Ambicare Health, 3Derm Systems Inc., Cuter Inc., Alma Lasers Ltd., Candela Corporation, Galderma S.A., V. Genentech Inc., Cynosure Inc., Michelson Diagnostics Ltd., Lumenis Ltd., Valeant Pharmaceuticals |
| Key Drivers | • Skin conditions are becoming more common • More cosmetic procedures being performed |
| RESTRAINTS | • Medical devices are subject to strict regulatory policies. • Uncertainty and problems with reimbursement |
Ans. The Dermatology Devices Market size was valued at US$ 7.99 billion in 2022.
Ans Medical devices are subject to strict regulatory policies, and Uncertainty and problems with reimbursement is the restraints of Dermatology devices Market.
Ans the impact of covid on Dermatology devices Market have a negative impact.
Ans. Ambicare Health, 3Derm Systems Inc., Cuter Inc., Alma Lasers Ltd., Candela Corporation, Galderma S.A., V. Genentech Inc. are the key players of the Dermatology devices Market
Ans. The Dermatology Devices Market is to grow at a CAGR of 11.8% over the forecast period 2023-2030.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia War
4.3 Impact of Ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Dermatology devices Market Segmentation, By Product type
8.1 Diagnostic Devices
8.1.1 Imaging devices
8.1.2 Dermatoscopes
8.1.3 Microscopes
8.2 Treatment Devices
8.2.1 Electrosurgery Devices
8.2.2 Cryotherapy Devices
8.2.3 Laser Devices
9. Dermatology devices Market Segmentation, By Application type
9.1 Skin Cancer Diagnosis
9.2 Psoriasis
9.3 Skin Rejuvenation
9.4 Warts
10. Dermatology devices Market Segmentation, By End user type
10.1 Hospitals
10.2 Clinics
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12. Company Profiles
12.1 Ambicare Health
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 3Derm Systems Inc.
12.3 Cuter Inc.
12.4 Alma Lasers Ltd.
12.5 Candela Corporation
12.6 Galderma S.A.
12.7 V. Genentech Inc.
12.8 Cynosure Inc.
12.9 Michelson Diagnostics Ltd.
12.10 Lumenis Ltd.
13. Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Wound Closure Market size was estimated USD 20.9billion in 2022 and is expected to reach USD 32.07billion by 2030 at a CAGR of 5.5% during the forecast period of 2023-2030.
In 2022, The Diabetic Neuropathy Market size amounted to USD 5.25 Billion & is estimated to reach USD 10.23 Billion by 2030 and increase at a compound annual growth rate of 8.7% between 2023 and 2030.
The Virtual Clinical Trials Market Size was valued at USD 7.91 billion in 2022, and is expected to reach USD 12.14 billion by 2030 and grow at a CAGR of 5.5% over the forecast period 2023-2030.
The Serum-free Media Market size was estimated USD 1.5 billion in 2022 and is expected to reach USD 4.0 billion by 2030 at a CAGR of 13.1% during the forecast period of 2023-2030.
The Irritable Bowel Syndrome Treatment Market Size was valued at USD 1.47 billion in 2022, and is expected to reach USD 2.81 billion by 2030, and grow at a CAGR of 8.4% over the forecast period 2023-2030.
The Artificial Intelligence in Healthcare Market Size was valued at USD 22.5 billion in 2023 and is expected to reach USD 271.1 billion by 2031 and grow at a CAGR of 36.5% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
